Robert L. Shields

5.4k total citations · 3 hit papers
28 papers, 4.3k citations indexed

About

Robert L. Shields is a scholar working on Physiology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert L. Shields has authored 28 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert L. Shields's work include Asthma and respiratory diseases (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (7 papers). Robert L. Shields is often cited by papers focused on Asthma and respiratory diseases (14 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (7 papers). Robert L. Shields collaborates with scholars based in United States, Switzerland and Netherlands. Robert L. Shields's co-authors include Leonard G. Presta, Kyu Hong, Y. Gloria Meng, Lori O'Connell, Rodney G. Keck, Paula Jardieu, Gordon M. Tomkins, Avram Hershko, Pierre S. Mamont and C Gorman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Robert L. Shields

27 papers receiving 4.0k citations

Hit Papers

Lack of Fucose on Human IgG1 N-Linked... 1971 2026 1989 2007 2002 2001 1971 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity
    2002 1.4k citations Robert L. Shields, Rodney G. Keck et al. Journal of Biological Chemistry profile →
  2. High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR
    2001 891 citations Robert L. Shields, Kyu Hong et al. Journal of Biological Chemistry profile →
  3. “Pleiotypic Response”
    1971 359 citations Robert L. Shields, Gordon M. Tomkins et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Shields United States 20 2.5k 2.4k 1.5k 716 536 28 4.3k
Maurizio Zanetti United States 36 1.5k 0.6× 715 0.3× 2.4k 1.6× 242 0.3× 125 0.2× 158 4.1k
Matthew L. Thomas United States 38 3.2k 1.3× 742 0.3× 4.9k 3.2× 514 0.7× 681 1.3× 64 6.9k
John D. Pound United Kingdom 28 1.3k 0.5× 827 0.3× 1.7k 1.1× 340 0.5× 140 0.3× 52 3.0k
J A Ledbetter United States 32 1.5k 0.6× 1.1k 0.4× 6.1k 4.0× 190 0.3× 679 1.3× 41 7.7k
Edda Fiebiger United States 39 1.7k 0.7× 670 0.3× 2.5k 1.6× 896 1.3× 945 1.8× 84 5.5k
Paul A. Edwards United Kingdom 38 3.0k 1.2× 653 0.3× 553 0.4× 313 0.4× 163 0.3× 128 5.2k
Marina Fabbi Italy 36 1.2k 0.5× 929 0.4× 3.5k 2.3× 119 0.2× 305 0.6× 93 5.2k
Takeshi Tsubata Japan 37 1.8k 0.7× 940 0.4× 4.2k 2.7× 218 0.3× 287 0.5× 126 5.7k
Nobuo Sakaguchi Japan 37 1.9k 0.8× 514 0.2× 2.7k 1.8× 237 0.3× 210 0.4× 119 4.7k
Lloyd M. Stoolman United States 30 1.6k 0.6× 549 0.2× 1.5k 1.0× 137 0.2× 1.4k 2.6× 59 3.5k

Countries citing papers authored by Robert L. Shields

Since Specialization
Citations

This map shows the geographic impact of Robert L. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Shields more than expected).

Fields of papers citing papers by Robert L. Shields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Shields. The network helps show where Robert L. Shields may publish in the future.

Co-authorship network of co-authors of Robert L. Shields

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Shields. A scholar is included among the top collaborators of Robert L. Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Shields. Robert L. Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, James K., Alan R. Leff, Martin J. Frey, et al.. (2015). Characterization of Tracheal Mast Cell Reactions in vivo. American Review of Respiratory Disease.
2.
Jackman, Janet, Yongmei Chen, Arthur Huang, et al.. (2010). Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling. Journal of Biological Chemistry. 285(27). 20850–20859. 68 indexed citations
3.
Wang, Yan, Denise Williams, Yaolin Wang, et al.. (2005). Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody. Molecular Cancer Therapeutics. 4(8). 1214–1221. 140 indexed citations
4.
Simmons, Laura, Dorothea Reilly, T. Shantha Raju, et al.. (2002). Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. Journal of Immunological Methods. 263(1-2). 133–147. 213 indexed citations
5.
Shields, Robert L., Rodney G. Keck, Lori O'Connell, et al.. (2002). Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity. Journal of Biological Chemistry. 277(30). 26733–26740. 1399 indexed citations breakdown →
6.
Shields, Robert L., Kyu Hong, Y. Gloria Meng, et al.. (2001). High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR. Journal of Biological Chemistry. 276(9). 6591–6604. 891 indexed citations breakdown →
7.
Tumas, Daniel B., Betty Chan, Winifred Werther, et al.. (2001). Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization. Journal of Allergy and Clinical Immunology. 107(6). 1025–1033. 36 indexed citations
8.
Oosterhout, A. J. M. van, Claudia L. Hofstra, Robert L. Shields, et al.. (1997). Murine CTLA4-IgG Treatment Inhibits Airway Eosinophilia and Hyperresponsiveness and Attenuates IgE Upregulation in a Murine Model of Allergic Asthma. American Journal of Respiratory Cell and Molecular Biology. 17(3). 386–392. 75 indexed citations
9.
Shields, Robert L., et al.. (1995). Anti-lgE Monoclonal Antibodies that Inhibit Allergen-Specific Histamine Release. International Archives of Allergy and Immunology. 107(1-3). 412–413. 24 indexed citations
10.
Shields, Robert L., B M Fendly, Leonard G. Presta, et al.. (1995). Inhibition of Allergic Reactions with Antibodies to IgE. International Archives of Allergy and Immunology. 107(1-3). 308–312. 144 indexed citations
11.
Presta, Leonard G., Steven J. Lahr, Robert L. Shields, et al.. (1993). Humanization of an antibody directed against IgE.. The Journal of Immunology. 151(5). 2623–2632. 359 indexed citations
12.
Haak‐Frendscho, Mary, et al.. (1993). Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo.. The Journal of Immunology. 151(1). 351–358. 33 indexed citations
13.
Caprioli, Joseph, et al.. (1987). Celiprolol Versus Timolol and Placebo: A Two Week Double-Blind Comparison. Journal of Ocular Pharmacology and Therapeutics. 3(1). 5–10. 2 indexed citations
14.
Weiss, Arthur, Paul Dazin, Robert L. Shields, Shu Man Fu, & Lewis L. Lanier. (1987). Functional competency of T cell antigen receptors in human thymus.. The Journal of Immunology. 139(10). 3245–3250. 30 indexed citations
15.
Greenspon, Lee, et al.. (1986). Purification of Ascaris suum antigen: Its allergenic activity in vitro and in vivo. Journal of Allergy and Clinical Immunology. 77(3). 443–451. 8 indexed citations
16.
Mapp, C, Jaakko Hartiala, Oscar L. Frick, Robert L. Shields, & Warren M. Gold. (1986). Immunologic and nonimmunologic responsiveness in ragweed-sensitized dogs. Journal of Applied Physiology. 61(4). 1467–1474. 1 indexed citations
17.
Mapp, C, Jaakko Hartiala, Oscar L. Frick, Robert L. Shields, & Warren M. Gold. (1985). Airway responsiveness to inhaled antigen, histamine, and methacholine in inbred, ragweed-sensitized dogs.. PubMed. 132(2). 292–8. 19 indexed citations
18.
Mapp, C, et al.. (1984). Cigarette smoke-induced bronchoconstriction in dogs: vagal and extravagal mechanisms. Journal of Applied Physiology. 57(4). 1261–1270. 20 indexed citations
19.
Brown, James K., Martin J. Frey, B. R. Reed, et al.. (1984). Radioenzymatic assay for measurement of tissue concentrations of histamine: Adaptation to correct for adherence of histamine to mechanical homogenizers. Journal of Allergy and Clinical Immunology. 73(4). 473–478. 2 indexed citations
20.
Scott, Walter A., Robert L. Shields, & Gordon M. Tomkins. (1972). Mechanism of Hormonal Induction of Tyrosine Aminotransferase Studied by Measurement of the Concentration of Growing Enzyme Molecules. Proceedings of the National Academy of Sciences. 69(10). 2937–2941. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizio Zanetti Breakdown of academic impact, for papers by Matthew L. Thomas Breakdown of academic impact, for papers by John D. Pound Breakdown of academic impact, for papers by J A Ledbetter Breakdown of academic impact, for papers by Edda Fiebiger Breakdown of academic impact, for papers by Paul A. Edwards Breakdown of academic impact, for papers by Marina Fabbi Breakdown of academic impact, for papers by Takeshi Tsubata Breakdown of academic impact, for papers by Nobuo Sakaguchi Breakdown of academic impact, for papers by Lloyd M. Stoolman
Rankless by CCL
2026